Need Help? Call 1­-866-­796-­7386
« back to stock screener

  AKBA stock: Akebia Therapeutics Inc

Current Rating
Hold/Sell

Previous Rating

Hold/Sell
Our Strong Buys
double the S&P500!
Learn more.
Company Statistics
Price
$2.52
Market Cap
466M
Sector
Health Care
Div. Growth
-
P/E
-
P/B
3.19
P/S
2.08
Dividend %
-
P/CF
8.4
P/FCF
-
Op. Cash Flow
-220.9K
FCF
-
Op. Margin
-135.10%
Net Margin
-142.00%
ROE
-154.70%
ROI
-109.40%
ROA
-48.10%
EPS Growth
35.70%
Current Ratio
2.0
Debt/Equity
38.90%
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Bristol-Myers Squibb Co (BMY) $56.32 - 3.50% 122.99B Strong Buy
Endo International PLC (ENDP) $4.99 - - 1.23B Strong Buy
Assertio Holdings Inc (ASRT) $1.35 - - 62.9M Strong Buy
Viatris Inc (VTRS) $12.20 - 3.60% 14.75B Strong Buy
Genesis Healthcare Inc (GENN) $0.20 - - 34.3M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More